France· FR:69515643
RIMIFON 500 mg/5 ml, solution injectable/pour perfusion
A isoniazid product containing isoniazide, registered in France by PHARMHOLDING (LUXEMBOURG). The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Isoniazid is registered in 15 of 19 countries.
Countries holding a registration under ATC J04AC01 (isoniazid), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 9 of them publish a price we can compare per daily dose
Isoniazid · ATC J04AC01
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of isoniazid costs, country by country.
Normalised to the WHO defined daily dose (0.3 g), the median price runs from $1.15 in France to $4.87 in Switzerland — a ×4.3 gap.
- France: $1.15 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Isoniazid · price per daily dose (0.3 g)
USD · FX 28 Sept 2026
- CH Switzerland$4.87
- FR France$1.15
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ISONIAZIDE
- Manufacturer
- PHARMHOLDING (LUXEMBOURG)
- Country
- France (FR)
- ATC code
- J04AC01
- ATC class
- Isoniazid
- Defined daily dose
- 0.3 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009347798486 ampoule(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
335 interactions on record for isoniazid.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Isoniazid · interactions on record
335 records
- 5 severe
- 233 moderate
- 26 minor
- 67 info
Most severe, free to view
- AlosetronA03AE01moderate
- Sodium picosulfateA06AB08moderate
- BudesonideA07EA06moderate
- LiraglutidA08AX02moderate
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Isoniazid in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCemidon Intravenoso 300mg/5ml solution for injection ampoulesImported (Spain)
- United StatesisoniazidMarlex Pharmaceuticals, Inc.
- NorwayIsoniazid SASykehusapotekene HF
- Japanイソニアジド
- CanadaPDP-ISONIAZIDPENDOPHARM DIVISION OF PHARMASCIENCE INC
- GermanyIsozidEsteve Pharmaceuticals Gmbh
- CzechiaISONIAZID
- ItalyNICOZID*5 fiale IM EV 500 mg 5 mlPIAM FARMACEUTICI SpA
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Inh Agepha
- Belgium · Nicotibine
- Bulgaria · Изонид, Изонид Дансон-Бг
- Czechia · Nidrazid
- Germany · Isozid, Isozid N
- Denmark · Isoniazid Oba
- Spain · Cemidon
- Finland · Tubilysin
- United Kingdom (Northern Ireland) · Isoniazid Dawa, Isoniazid Macleods Pharma Uk
- Greece · Dianicotyl
- Hungary · Isonicid
- Iceland · Tibinide
- Italy · Nicozid
- Luxembourg · Nicotibine
- Netherlands · Isoniazide Costero
- Poland · Nidrazid
- Portugal · Isoniazida Labesfal
- Romania · Izoniazidă Arena, Izoniazida Atb
- Sweden · Tibinide
- Slovakia · Nidrazid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cb08419f-45dc-4f08-bdb2-37a1768169fe GET /v1/drugs/cb08419f-45dc-4f08-bdb2-37a1768169fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69515643",
"date_amm": "2016-11-29",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ISONIAZIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable ou pour perfusion",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about isoniazid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.